API reference
Mirtazapine
- CAS number
- 85650-52-8
- Molecular formula
- C17H19N3
- Molecular weight
- 265.35 g/mol
About this molecule
Mirtazapine is a tetracyclic piperazino-azepine antidepressant agent that was initially approved for the treatment of major depressive disorder (MDD) in the Netherlands in 1994. This drug was first manufactured by Organon Inc., and received FDA approval in 1997 for the treatment of major depressive disorder. The effects of this drug may be observed as early as 1 week after beginning therapy. In addition to its beneficial effects in depression, mirtazapine has been reported to be efficacious in the off-label management of various other conditions. It may improve the symptoms of neurological disorders, reverse weight loss caused by medical conditions, improve sleep, and prevent nausea and vomiting after surgery.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- 5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene
- InChIKey
- RONZAEMNMFQXRA-UHFFFAOYSA-N
- SMILES
- CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4
- Other CAS numbers recorded
- 61337-67-5 · 159355-60-9
- PubChem CID
- 4205
Also known as
mirtazapine · Remeron · Mepirzepine · 6-Azamianserin · Remergon · Zispin · Promyrtil · Remergil
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.